Satellos Bioscience Inc. Brief: Co Says Intends to Submit a Regulatory Package in July to Initiate a First-in-human Phase 1 Clinical Trial, in Q3 2024
Satellos Bioscience Inc. Brief: Co Says Intends to Submit a Regulatory Package in July to Initiate a First-in-human Phase 1 Clinical Trial, in Q3 2024
Satellos生物科技公司简介：公司表示打算在2024年第三季度提交一份监管申请文件，以启动第一阶段人体临床试验。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册